This invention relates to sulfonamide derivative of formula (I), to their use in medicine, to compositions containing them, to processes for their preparation, and to intermediates used in such processes.
These compounds are inhibitors of Nav1.7.
N-SULFONYLBENZAMIDE DERIVATIVES USEFUL AS VOLTAGE GATED SODIUM CHANNEL INHIBITORS
申请人:Pfizer Limited
公开号:EP2593432A1
公开(公告)日:2013-05-22
SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN
申请人:Pfizer Limited
公开号:EP2593427B1
公开(公告)日:2014-12-24
US8592629B2
申请人:——
公开号:US8592629B2
公开(公告)日:2013-11-26
[EN] SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN<br/>[FR] COMPOSÉS CHIMIQUES
申请人:PFIZER LTD
公开号:WO2012007883A1
公开(公告)日:2012-01-19
The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I):or a pharmaceutically acceptable salt thereof, wherein Ar1, X, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.